ABSTRACT. Monoclonal antibodies (mAbs) were prepared against the 8597/CV94 strain of turkey rhinotracheitis virus (TRTV). These mAbs were used to investigate antigenic relationships among three strains (8597/CV94, 1162/92 and CVL14/1 strain) of TRTV, together with polyclonal chicken and rabbit antisera to 8597/CV94 strain, and guinea pig antisera to each of the three strains. Thirty mAbs to the glycoprotein (G:3 clones), fusion (F1:6 clones), phosphorylated (P:6 clones), nucleocapsid (N:12 clones), and matrix (M:3 clones) proteins of viral antigen were obtained by cell fusion. Among these, two mAbs to F1 protein showed virus neutralizing activity. The results of ELISA test indicated that some mAbs only reacted to the 8597/CV94 strain, some reacted to 8597/CV94 and 1162/92 strains, and others reacted to all three viral strains. In neutralization tests with the three virus strains, polyclonal chicken and rabbit antisera against the 8597/ CV94 strain showed the same antibody titers. Results with four neutralizing mAbs including two previously reported mAbs [Ref. 21] indicated the titers of two mAbs (Pn2-2E and Pn3-2F) to 8597/CV94 were much higher than those to the other two viral strains. No differences were observed in the titers of the other two mAbs (Pn01-8E and Pn06-4D) against any viral strains. In cross-neutralization tests with polyclonal guinea pig antisera, there was some variations among viral strains. This work demonstrated that the Japanese isolate 8597/CV94 of TRTV is somewhat different in antigenicity from two British isolates from chickens and turkeys. strains isolated in the UK from chickens and turkeys by enzyme-linked immunosorbent assay (ELISA) and virus neutralization tests with the newly produced mAbs and polyclonal antisera.
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MATERIALS AND METHODS

Viruses:
The virus used in this study was 8597/CV94 strain isolated from chickens with SHS. British strains, 1162/92 isolated from chickens [10] and CVL14/1 isolated from turkeys [24] , were supplied by Dr. R. E. Gough (Central Veterinary Laboratory, UK). The viruses were propagated in Vero cells, and purified from infected culture fluid by differential ultracentrifugation and by sedimentation through a 20-60% discontinuous sucrose gradient at 100,000 ×g for 90 min. The virus band was collected and used as purified virus for immunization and the ELISA antigens.
Antisera: Guinea pigs were immunized with the three strains of TRTV. Specific pathogen free chickens and rabbits were immunized with the 8597/CV94 strain. The virus suspensions containing 1.0 × 10 6.0 TCID 50 /ml emulsified with an equal amount of Freund's complete or incomplete adjuvant were employed as immunogens. Rabbits and guinea pigs were injected intramuscularly and then subcutaneously at two-week intervals with 1 or 0.5 ml of the virus. Chickens were given 0.1 ml of the virus suspension without adjuvant intraocularly twice at two-week intervals. The animals were bled two weeks after the last injection, and the sera were stored at 20°C until use.
MAbs: Purified virus for immunization of BALB/c mice was emulsified with Freund's complete adjuvant, and injected intraperitoneally twice at two-week intervals. Four Turkey rhinotracheitis virus (TRTV) also known as avian pneumovirus, is classified into the genus Pneumovirus of the family Paramyxoviridae [5] . The virus has been isolated from turkeys in some European countries [8, 23, 25] and South Africa [3] . In addition, the virus could be considered as a factor in swollen head syndrome (SHS) in chickens, and was isolated from chickens with SHS in France [18] , the United Kingdom (UK) [11] , South Africa [4] and Taiwan [15] .
In Japan, although SHS was first observed in Hyogo prefecture in 1989, its causative agents have not been identified in affected chickens [22] . In the spring of 1994, we first isolated TRTV from commercial broiler chickens with SHS in Miyazaki prefecture, and designated this agent 8597/CV94 [19] . The antigenic properties of the 8597/ CV94 strain of TRTV have previously been reported using monoclonal antibodies (mAbs) to fusion (F; F1) and matrix (M) proteins [21] .
Recently, TRTV strains were isolated from SHS affectedchickens one after another in Japan (unpublished data). However, comparative antigenic relationships and/or variations between strains of TRTV have not been investigated. Only a few reports regarding antigenic diversity of TRTV have been published by groups in the UK [6, 7] .
In the present study, we produced new mAbs to the 8597/ CV94 strain, and compared this strain with two TRTV days before fusion, mice were injected intravenously with 100 µg of virus in phosphate-buffered saline (PBS pH 7.2). Immune splenocytes were collected and fused at a ratio of 1:5 splenocytes with SP2/0 Ag-14 myeloma cells by the standard procedure of Koehler and Milstein [12] . The presence of TRTV-specific antibodies was examined by ELISA using microplates coated with the solubilized antigen. Screened hybridoma was cloned three times by the limiting dilution method and propagated both in culture and in mouse ascitic fluid. MAbs were purified using mAb Trap G II or E-Z-SEP TM (Pharmacia), and adjusted to 1 mg/ ml in PBS.
Characterization of mAbs: MAb specificity was determined by Western blotting analysis. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis was carried out on 12% slab gels as described by Laemmli [13] . Each purified viral antigen was solubilized in sample buffer with 2-mercaptoethanol, heated at 100°C for 2 min and separated at a constant voltage of 200 V. The viral proteins were transferred from the gel onto nitrocellulose membranes. The nitrocellulose membrane strips with bound viral proteins were blocked with Block Ace (blocking milk; Yukijirushi) at 4°C overnight then incubated with each mAb (undiluted culture fluid of the hybridoma) at room temperature for 1 hr. After washing, the nitrocellulose membrane strips were incubated with rabbit anti-mouse peroxidase-conjugated IgG (Jackson Immuno-Research) at a dilution of 1:6,000 in PBS with 1% Tween 20 for 1 hr. The nitrocellulose strips were developed with a VECTASTAIN DAB (3,3'-diaminobenzidine) substrate kit (Funakoshi). Immunoglobulin isotype was determined with a mouse mAb isotyping kit (Amersham). Biological activities of mAbs were examined by neutralization and fusion inhibition tests as described by Beeler and van Wyke Coelingh [2] . For neutralization test, serial two-fold dilutions of purified mAbs were mixed with 200 TCID 50 of strain 8597/CV94 and incubated for 1 hr at 37°C. Then, 100 µl aliquots of the virus-antibody mixtures were transferred to monolayers of Vero cells in 96-well microplates. For fusion inhibition test, Vero cell monolayers were infected with the viruses at moi=0.01. After 1 hr incubation, the viruses were replaced by 50 µl serial two-fold dilutions of purified mAbs. Neutralization and fusion inhibition titers were expressed as the reciprocal of maximum dilution of mAbs which completely inhibited the infection or syncytium formation with the virus, respectively.
ELISA test: ELISA antigen preparations and procedures were essentially the same as those described by Tanaka et al. [20] . Individual microplate wells were coated with viral antigen preparation diluted to give 1 µg of protein per well. Purified mAbs were diluted 1:100 and tested for their titer by ELISA. Results were expressed as relative optical density (OD) value ( ~+++): ; < 0.149, +; 0.15-0.49, ++; 0.50-1.00, +++; > 1.00.
Neutralization test: The neutralization test procedure was performed on microplates as described above. Serial twofold dilutions of polyclonal antiserum or purified mAb showing neutralization activities (previously reported mAbs Pn2-2E and Pn3-2F [21] and Pn01-8E, Pn06-4D) were mixed with 200 TCID 50 of each virus. Antigenic similarities among the TRTV strains examined by polyclonal guinea pig antisera were formulated as described by Archetti and Horsfall [1] (formula; r 1 × r 2 , on condition that r n = heterologous neutralization titer/homologous neutralization titer).
RESULTS
Characterization of mAbs:
The specificities, subclasses and biological activities of all 30 mAbs are shown in Table  1 . By western blotting analysis, 3 mAbs (Pn03-10F, Pn04-3D and Pn-06-1D) yielded a 82 kilodalton (kDa) protein band corresponding to G, 6 mAbs (Pn01-8E, Pn02-2H, Pn02-4B, Pn06-4D, Pn08-12D and Pn14-9B) yielded a 52 kDa protein band corresponding to F1, 12 mAbs (Pn01-9A, Pn02-2F, Pn03-2G, Pn03-3A, Pn03-3F, Pn03-3H, Pn03-9A, Pn08-4D, Pn11-7E, Pn11-8B, Pn12-4C and Pn12-4D) 
yielded a 43 kDa protein band corresponding to N, 6 mAbs (Pn06-2G, Pn13-4E, Pn14-7G, Pn15-8G, Pn16-6H and Pn16-8C) yielded a 38 kDa protein band corresponding to P, and 3 mAbs (Pn08-6C, Pn15-2C and Pn15-9H) yielded a 34 kDa protein band corresponding to M. The isotypes of the mAbs were IgG1, IgG2a, IgG2b and IgA, respectively. The mAbs were also examined for their abilities to neutralize viral infectivity and to inhibit syncytium formation in vitro. Two of six F1-specific mAbs, Pn01-8E and Pn06-4D, neutralized the virus infectivity. These mAbs also inhibited syncytium formation in vitro. Four other F1-specific mAbs (Pn02-2H, Pn02-4B, Pn08-12D and Pn14-9B) did not show neutralizing or fusion inhibition activity. G-, N-, P-and Mspecific mAbs showed neither neutralizing nor fusion inhibition activity (Table 1) .
ELISA tests using mAbs:
The results of ELISA test using mAbs against 8597/CV94 are shown in Table 2 . There were marked variations between strains in the reactivities to the mAbs. Some mAbs only reacted to the 8597/CV94 strain, 8597/CV94 and 1162/92 strains, or to all three virus strains. This tendency was observed in all groups of mAbs recognizing each antigen (Table 2) .
Neutralization tests using polyclonal antisera and mAbs against 8597/CV94:
The results of neutralization test using polyclonal chicken and rabbit antisera against 8597/CV94 strain and mAbs containing the previous products which showed neutralization ability are shown in Table 3 . Using polyclonal antisera, the three TRTV strains were clearly shown to be related. The differences in neutralization titer were less than 4-fold. However, in the case of mAbs, the antibody titer levels of neutralization varied among strains. In Pn06-4D, all strains showed very close relationships. In Pn01-8E, the antibody titers of 8597/CV94 and CVL14/1 were close, but that of 1162/92 was low in comparison with the other two strains. In Pn2-2E and Pn3-2F, the antibody titers of 8597/CV94 were 32 to 256-fold higher than those of the other two strains (Table 3) .
Cross-neutralization tests using polyclonal antisera: Cross-neutralization tests were performed using polyclonal guinea pig antisera against each TRTV strain, and correlation coefficients of the results were calculated using the formula of Archetti and Horsfall. While all the strains examined were clearly serologically related, the abilities to neutralize viral infectivity against each strain showed some differences ( Table 4 ). The correlation rate between 8597/ CV94 and 1162/92 was 70%, and that between 8597/CV94 and CVL14/1 was 35% (Table 5) . 
DISCUSSION
Studies of the antigenic relationships using conventional techniques have indicated close similarities between different TRTV isolates [9] . However, the availability of mAbs to the TRTV make studies on to analyse antigenic diversity of the different strains. Therefore, we produced mAbs for comparison of antigenicity of TRTV (8597/CV94) isolated in Japan with those of British isolates (1162/92, CVL14/1).
In ELISA test using 30 mAbs with solubilized antigens, some of the mAbs reacted to all of the three strains examined, but some reacted to 8597/CV94 and 1162/92, and the rest reacted to only 8597/CV94. Similar observations were obtained by western blotting analysis (data not shown). Antigenic variations of F and G proteins in respiratory syncytial virus (RSV) and TRTV [6, 14] have been reported. These results suggested the antigenic variation amongst TRTV strains may be dependent on F and other proteins. Solubilization of antigens with Nonidet P-40 (NP40) resulted in marked reduction of the reactivity of all three strains in ELISA test (data not shown). These results were different from those of Collins et al. [6] who reported that the variation between TRTV strains could be detected more clearly when the antigen was used in the form of NP40-extracted than freeze-thawed preparations. Thus, it is important to consider the solubilization procedure for preparation of ELISA antigens in the field.
Previously, we produced two neutralizing mAbs to F1 protein of the 8597/CV94 strain, and reported that they also inhibited syncytium formation in vitro [21] . Two of six F1-specific mAbs obtained in this study also had both neutralized viral infectivity and inhibited syncytium formation. This result supported the earlier findings that fusion inhibitory activity was correlated with neutralization [16] . The antigenic differences between 8597/CV94 strain and other two strains were clearly demonstrated by neutralization tests using these four mAbs. Although neutralization titers of Pn01-8E and Pn06-4D to all three strains were similar, they were much higher for Pn2-2E and Pn3-2F to 8597/CV94 virus than to the other two viruses. The antibody titers to 8597/CV94 were 32 to 256-fold higher than those to the other two strains. This result was similar to that in RSV showing antigenic variation in the neutralization epitopes of F glycoprotein [2] . Moreover, in RSV and TRTV, it has been reported that both F and G proteins induce neutralizing antibodies [6, 14, 16] , but three G-specific mAbs obtained in this study were able to neither neutralize viral infectivity nor inhibit syncytium formation. As the antigenic variation of G protein was reported in TRTV [6] , the G protein of RSV also shows extensive variation. The reason why the anti-G mAbs did not neutralize the virus may be a consequence of variation of the epitope relevant to neutralization.
The similarity between 8597/CV94 and CVL14/1 detected using polyclonal antisera from guinea pigs was relatively low in comparison with that of 8597/CV94 and 1162/92. Therefore the evidence for antigenic differences between 8597/CV94 and two Britsh strains is sufficient.
In Japan, serological surveys using ELISA [20] and neutralization test [17] indicated that the TRTV infected chicken flocks around 1988 or 1989, and spread thereafter. After our initial isolation of TRTV, two other groups succeeded in isolation of TRTV in other parts of the country (personal communications). Cook et al. [7] reported that isolates of TRTV in South Africa in 1978 and the UK in 1985 were more closely related than were isolates from the UK and France detected within a few months of each other. These results suggested that the divergence of TRTV is common phenomenon. Whether such a degree of variation influenced the efficacy of vaccines is unclear, but it seems that the comparison of antigenic properties among more isolates including those from Japan is required to develop effective vaccines. More detailed studies of the serological and molecular characteristics in relation to diversity of TRTV in Japan are needed.
In conclusion, the TRTV strain 8597/CV94 isolated in Japan differs in its antigenic properties from two strains 1162/92 and CVL14/1 isolated in the UK. In addition, the development of mAbs as a major tool for analysis of the antigenicity of TRTV will facilitate characterization of the properties of the various strains. The availability of these mAbs will provide valuable tools for future serological, epidemiological and diagnostic studies.
